Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Current Blog Category: Gene Therapy
What Is Gene Editing? How It Works In 2-Minutes

What Is Gene Editing? How It Works In 2-Minutes

Apr 17, 2021

Contributing Author : Gina Big Picture    Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 – an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the…

Read More
Biotech CEO Jeff Galvin Explains Cell and Gene Therapy to Stony Brook Biomedical Engineering Society

Biotech CEO Jeff Galvin Explains Cell and Gene Therapy to Stony Brook Biomedical Engineering Society

Apr 9, 2021

Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies (AGT), gives an inspiring talk at the Stony Brook University Biomedical Engineering Society (BMES) detailing his journey from working closely with computers in Silicon Valley to leveraging the progression of gene and cell…

Read More
Covid-19 Testing Lab Self Swab Instructions - How to Self Test by American Gene Technologies

Covid-19 Testing Lab Self Swab Instructions – How to Self Test by American Gene Technologies

Apr 9, 2021

Subscribe to our YouTube Channel As the COVID-19 Pandemic continues to affect the nation, American Gene Technologies (AGT) developed its own coronavirus testing lab to ensure the health and safety of employees. Today, the tests are available to members of the community. In this video,…

Read More
COVID-19 PRC Testing Lab at American Gene Technologies

COVID-19 PRC Testing Lab at American Gene Technologies

Apr 9, 2021

Subscribe to our YouTube Channel As the COVID-19 Pandemic continues across the globe, Jeff Galvin, CEO of American Gene Technologies (AGT), explains the measures AGT has taken to keep employees protected. AGT developed its own COVID-19 testing lab using high accuracy RT-PCR tests. These tests…

Read More
Technology Transfer, A Catalyst For Gene Therapy Startups | The Spark Therapeutics Example

Technology Transfer, A Catalyst For Gene Therapy Startups | The Spark Therapeutics Example

Apr 5, 2021

Contributing Author: Gina Hagler   The ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline. Traditionally, pharmaceutical companies have developed small molecule medicines such as Zantac or Lipitor to treat conditions…

Read More
What Is Gene Therapy? How It Works In 2-Minutes

What Is Gene Therapy? How It Works In 2-Minutes

Mar 31, 2021

Contributing Author: Gina Hagler   Big Picture    Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing are all forms of genomic medicine1 – an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the…

Read More
Biotech IPOs 2020 and M&A Trends

Biotech IPOs 2020 and M&A Trends

Mar 22, 2021

  Contributing Author John Vandermosten, Senior Biotechnology Analyst Transaction Trends 2020    Life sciences transactions have boomed over the last year.  Merger and acquisition (M&A) activity distinguished itself with several large and meaningful deals, but it was initial public offerings (IPOs) that stole the spotlight…

Read More
Rare Disease Moms Make Their Voices Heard | Three Inspirational Stories

Rare Disease Moms Make Their Voices Heard | Three Inspirational Stories

Feb 28, 2021

Contributing Author: Gina Hagler There are 7,000 known rare diseases in the world. Each of them affects less than 1% of the global population, although ultra-rare diseases affect fewer still. The majority of rare and ultra-rare diseases are monogenic in nature, meaning they are caused…

Read More
5 Ways Gene Therapy Companies are Transforming Rare Disease Cures

5 Ways Gene Therapy Companies are Transforming Rare Disease Cures

Feb 12, 2021

Contributing Author: Gina Hagler Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it difficult and expensive to bring together enough individuals for a clinical-stage trial. The small patient population of fewer than 1% of the population…

Read More
A SPACtacular Way to Go Public

A SPACtacular Way to Go Public

Feb 11, 2021

  Contributing Author John Vandermosten, Senior Biotechnology Analyst What Is A SPAC Anyway? 2020 turned out to be a fantastic year for private companies to go public.  In a hot year for initial public offerings (IPOs), one type of IPO called a Special Purpose Acquisition…

Read More

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!

Blog Categories

Follow AGT on Social Media